BioCryst Pharmaceuticals
BCRX
#4376
Rank
$2.33 B
Marketcap
$9.33
Share price
-2.41%
Change (1 day)
18.70%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of December 2025 : -$0.12 Billion USD

According to BioCryst Pharmaceuticals 's latest financial reports the company has -$0.12 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-$0.12 Billion-74.96%
2024-12-31$-$0.48 Billion4.48%
2023-12-31$-$0.46 Billion54.63%
2022-12-31$-$0.3 Billion175.36%
2021-12-31$-$0.11 Billion455.43%
2020-12-31$-$19.27 Million-150.36%
2019-12-31$$38.25 M-22.31%
2018-12-31$$49.23 M-41.22%
2017-12-31$$83.76 M5208.43%
2016-12-31$$1.57 M-96.69%
2015-12-31$$47.72 M-36.9%
2014-12-31$$75.63 M-6817.14%
2013-12-31$-$1.13 Million148.02%
2012-12-31$-$0.46 Million-103.07%
2011-12-31$$14.8 M-77.4%
2010-12-31$$65.5 M-24.07%
2009-12-31$$86.26 M85.81%
2008-12-31$$46.42 M-28.47%
2007-12-31$$64.9 M206.81%
2006-12-31$$21.15 M-63.8%
2005-12-31$$58.44 M99.22%
2004-12-31$$29.33 M3.12%
2003-12-31$$28.44 M-29.11%
2002-12-31$$40.12 M-29.37%
2001-12-31$$56.81 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
$22.61 B-19,082.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$21.48 B-18,134.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$1.14 B-1,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
$2.10 B-1,867.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-$0.13 Billion 7.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.52 B-542.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$7.17 M-106.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
$15.95 M-113.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.58 B-588.87%๐Ÿ‡บ๐Ÿ‡ธ USA